Table 3.
Patients’ characteristics based on adherence to MD (assessed by the KIDMED)
| Variable | KIDMED ≤2 Poor MD adherence (n = 17) | KIDMED 3–6 moderate MD adherence (n = 51) | KIDMED ≥7 High MD adherence (n = 31) | p value |
|---|---|---|---|---|
| Age, mean±SD, years | 15.2±2 | 14.2±2.8 | 14.2±2.6 | 0.57 |
| Female, n (%) | 4 (23.5) | 26 (51) | 8 (25.8) | 0.02 |
| Disease duration, median [IQR] | 2.9 [1–4.4] | 2.5 [1–4.5] | 1.22 [0.7–3] | 0.59 |
| Z-score BMI, mean±SD | −0.7±1.2 | −0.34±1.1 | −0.3±1.3 | 0.48 |
| PCDAI, median [IQR] | 0 [0–1.25] | 0 [0–2.5] | 0 [0–5] | 0.68 |
| PGA, normal, not at all ill, n (%) | 14 (82.2) | 40 (78.4) | 27 (87.1) | 0.35 |
| CRP, mg/dL | 0.2 [0.05–0.5] | 0.2 [0.05–0.5] | 0.2 [0.06–0.5] | 0.14 |
| FC, μg/g, median [IQR] | 59 [17.5–781.5] | 84 [13–454] | 41 [20–135] | 0.13 |
| Mini Index, median [IQR] | 0 [(−2.5)−11] | 2 [(−3)−8] | −2 [(−3)−6] | 0.62 |
| IMPACT, mean±SD | 75.2±14.1 | 71±14 | 76.2±11 | 0.21 |
| I-MEDAS, mean± SD | 5.76±1.5 | 6.9±1.5 | 8.13±1.7 | <0.001 |
| Total biologics, n (%) | 15 (88.2) | 44 (86.3) | 25 (80.6) | 0.72 |
Variables are presented as mean ± SD or as Median [IQR] when variables are not normally distributed.
PGA, Physician Global Assessment; PCDAI, Pediatric Crohn’s Disease Activity Index, normal range PCDAI ≤10; CRP, C-reactive Protein, normal range CRP <0.5; ESR, erythrocyte sedimentation rate.